About: Baclofen in the Treatment of Spasticity

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Baclofen in the Treatment of Spasticity Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/bmj/1971/volume_4/issue_5778/w
Subject	Papers and Originals Clinical trials (epidemiology)
Title	Baclofen in the Treatment of Spasticity
has manifestation of work	http://hub.abes.fr/bmj/periodical/bmj/1971/volume_4/issue_5778/B36F82B5D1453F78E053120B220A32C2/m/web http://hub.abes.fr/bmj/periodical/bmj/1971/volume_4/issue_5778/B36F82B5D1453F78E053120B220A32C2/m/print
related by	http://hub.abes.fr/bmj/periodical/bmj/1971/volume_4/issue_5778/B36F82B5D1453F78E053120B220A32C2/authorship/1 http://hub.abes.fr/bmj/periodical/bmj/1971/volume_4/issue_5778/B36F82B5D1453F78E053120B220A32C2/authorship/2
Abstract	Baclofen† (Lioresal), a derivative of gamma-aminobutyric acid, was introduced in 1966 as a possible treatment for spasticity due to corticospinal tract lesions. Preliminary studies suggested that it may be more effective than other spasmolytic agents currently available, and a double-blind controlled trial in a group of 23 patients against placebo has shown it to be significantly more effective.
article type	research-article
is part of this journal	British Medical Journal
PubMed ID	4938243

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata